ChemLex, an AI-for-science startup, has raised USD 45 million in seed funding to launch a self-driving laboratory for drug discovery in Singapore.

• Technology: The laboratory is autonomous and integrates artificial intelligence with automated experimentation.
• Operations: The Singapore facility will function as the company’s global headquarters and primary base for research activities.
• Objective: The platform is intended to accelerate the drug discovery process.

This summary is based on a press release issued by ChemLex.